Akoustis Technologies Inc. specializes in the design and manufacturing of advanced semiconductor materials and radio frequency (RF) filters for high-performance wireless applications. The company focuses on developing innovative solutions utilizing its patented technology, which allows for the production of high-quality bulk acoustic wave (BAW) filters. These filters are critical components in mobile devices, Internet of Things (IoT) applications, and various communication systems, enabling improved performance and efficiency in transmitting and receiving signals. Through its cutting-edge technology and manufacturing capabilities, Akoustis aims to meet the growing demand for faster and more reliable wireless connectivity in today's increasingly connected world. Read More
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies, today announced the closing of its upsized initial public offering of 17,650,000 shares of its common stock, at an initial public offering price of $18.00 per share, occurred on January 12, 2026. In addition, the underwriters exercised in full their option to purchase an additional 2,647,500 shares of Aktis’ common stock, at the initial public offering price of $18.00 per share. The sale of the 2,647,500 additional shares is expected to close on January 14, 2026, subject to satisfaction of customary closing conditions. The aggregate gross proceeds from the initial public offering, including the full exercise of the underwriters’ option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $365.4 million. All of the shares of common stock were offered by Aktis. Aktis’ common stock began trading on the Nasdaq Global Select Market on January 9, 2026 under the ticker symbol “AKTS.”
Committed to Full Continuity in Delivering Next-Generation BAW High-Band RF Filters to Customers Around the World Filing to Ensure Business Sold Free and Clear of Qorvo Infringement Following Final Judgement and Required Cleansing Process
Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has voluntarily filed for chapter 11 relief in the United States Bankruptcy Court for the District of Delaware (the “Court”) to provide the Company with the flexibility to complete its ongoing marketing and sale process while continuing to deliver for its valued customers around the world. The voluntary chapter 11 filing follows the Company’s recent legal case with Qorvo, Inc., in which Akoustis was ordered to pay a total judgement of approximately $59 million in damages, fees, and interest related to allegations of trade secret misappropriation and patent infringement.
These five companies, all trading under $0.10, present speculative opportunities for investors looking to find undervalued businesses with tremendous upside potential. As October unfolds, these stocks may witness significant market movements, offering attractive entry points for those willing to take calculated risks.
Akoustis Technologies shares are trading higher Tuesday after the company announced it has received an additional purchase order for $13 million from an existing customer. Here's a look at what's going on:
Charlotte, NC, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Akoustis Receives an Additional Purchase Order for $13 Million XBAW® Filters from Existing Tier-1 Customer
